News

Omeros said that OMS302 is its proprietary PharmacoSurgery product in development to maintain mydriasis (pupil dilation) and reduce postoperative pain and inflammation following cataract and other lens replacement

Twynsta is expected to be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving

Novavax’s newly patented influenza vaccine technology utilises hemagglutinin (HA) and neuraminidase (NA), major proteins found on the surface of the influenza virus together with a single influenza matrix

The ProFAST+ assay is a multiplex, real-time RT-PCR (polymerase chain reaction) test that detects influenza A from nasopharyngeal swabs. It uses the same internal control and format as

Alcon’s operating income rose 18.8% to $751m, or 39.8% of sales. Non-GAAP adjusted operating income would have increased 19.5% to $755m, or 40.0% of sales. Net earnings in

Ampio and DMI said that the acquisition is expected to provide Ampio access to all rights, royalties and patents associated with DMI’s assets, drugs for male sexual dysfunction

Tibotec Pharma said that, TMC278 will be the third anti-HIV compound to be introduced by the company, if approved by FDA. Tibotec Pharma has applied for the approval

With the completion of this acquisition, QPS further expands its linearly integrated resources and services which consists of drug discovery and development from preclinical to clinical studies for

Abviva said that the Mammastatin technology continues to increase its protection as evidenced by the grant of patents around its core technology. Reportedly, in recent months, the Japanese